176 related articles for article (PubMed ID: 38424195)
21. NSUN2-mediated RNA m
Luo G; Xu W; Chen X; Wang S; Wang J; Dong F; Hu DN; Reinach PS; Yan D
Epigenetics; 2022 Aug; 17(8):922-933. PubMed ID: 35757999
[TBL] [Abstract][Full Text] [Related]
22. NSUN2 modified by SUMO-2/3 promotes gastric cancer progression and regulates mRNA m5C methylation.
Hu Y; Chen C; Tong X; Chen S; Hu X; Pan B; Sun X; Chen Z; Shi X; Hu Y; Shen X; Xue X; Lu M
Cell Death Dis; 2021 Sep; 12(9):842. PubMed ID: 34504059
[TBL] [Abstract][Full Text] [Related]
23. 5-methylcytosine promotes pathogenesis of bladder cancer through stabilizing mRNAs.
Chen X; Li A; Sun BF; Yang Y; Han YN; Yuan X; Chen RX; Wei WS; Liu Y; Gao CC; Chen YS; Zhang M; Ma XD; Liu ZW; Luo JH; Lyu C; Wang HL; Ma J; Zhao YL; Zhou FJ; Huang Y; Xie D; Yang YG
Nat Cell Biol; 2019 Aug; 21(8):978-990. PubMed ID: 31358969
[TBL] [Abstract][Full Text] [Related]
24. RNA methyltransferase NSUN2 promotes gastric cancer cell proliferation by repressing p57
Mei L; Shen C; Miao R; Wang JZ; Cao MD; Zhang YS; Shi LH; Zhao GH; Wang MH; Wu LS; Wei JF
Cell Death Dis; 2020 Apr; 11(4):270. PubMed ID: 32332707
[TBL] [Abstract][Full Text] [Related]
25. Aberrant NSUN2-mediated m
Sun Z; Xue S; Zhang M; Xu H; Hu X; Chen S; Liu Y; Guo M; Cui H
Oncogene; 2020 Nov; 39(45):6906-6919. PubMed ID: 32978516
[TBL] [Abstract][Full Text] [Related]
26. NSUN2-mediated M
Wang H; Feng J; Zeng C; Liu J; Fu Z; Wang D; Wang Y; Zhang L; Li J; Jiang A; He M; Cao Y; Yan K; Tang H; Guo D; Xu K; Zhou X; Zhou L; Lan K; Zhou Y; Chen Y
Emerg Microbes Infect; 2023 Dec; 12(1):2178238. PubMed ID: 36748584
[TBL] [Abstract][Full Text] [Related]
27. NSUN2-Mediated m
Lu J; Zhang M; Liu Z; Guo L; Huang P; Xia W; Li J; Lv J; Cheung HH; Ding C; Li H; Huang B
Lab Invest; 2024 Apr; 104(4):100327. PubMed ID: 38237738
[TBL] [Abstract][Full Text] [Related]
28. FOXC2-AS1 stabilizes FOXC2 mRNA via association with NSUN2 in gastric cancer cells.
Yan J; Liu J; Huang Z; Huang W; Lv J
Hum Cell; 2021 Nov; 34(6):1755-1764. PubMed ID: 34324140
[TBL] [Abstract][Full Text] [Related]
29. RNA methyltransferase NSUN2 promotes hypopharyngeal squamous cell carcinoma proliferation and migration by enhancing TEAD1 expression in an m
Chen L; Ding J; Wang B; Chen X; Ying X; Yu Z; Dong P
Exp Cell Res; 2021 Jul; 404(2):112664. PubMed ID: 34048786
[TBL] [Abstract][Full Text] [Related]
30. E2F1 Promotes Progression of Bladder Cancer by Modulating RAD54L Involved in Homologous Recombination Repair.
Mun JY; Baek SW; Park WY; Kim WT; Kim SK; Roh YG; Jeong MS; Yang GE; Lee JH; Chung JW; Choi YH; Chu IS; Leem SH
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33261027
[TBL] [Abstract][Full Text] [Related]
31. 5-methylcytosine modification by
Liu M; Guo G; Qian P; Mu J; Lu B; He X; Fan Y; Shang X; Yang G; Shen S; Liu W; Wang L; Gu L; Mu Q; Yu X; Zhao Y; Culleton R; Cao J; Jiang L; Wellems TE; Yuan J; Jiang C; Zhang Q
Proc Natl Acad Sci U S A; 2022 Mar; 119(9):. PubMed ID: 35210361
[TBL] [Abstract][Full Text] [Related]
32. Hsa_circ_0007990 promotes breast cancer growth via inhibiting YBX1 protein degradation to activate E2F1 transcription.
Xu T; Xiong M; Hong Q; Pan B; Xu M; Wang Y; Sun Y; Sun H; Pan Y; Wang S; He B
Cell Death Dis; 2024 Feb; 15(2):153. PubMed ID: 38378679
[TBL] [Abstract][Full Text] [Related]
33. LncRNA HOST2 promotes NSUN2-mediated breast cancer progression via interaction with ELAVL1.
Wang X; Liu D; Hua K; Fang L
Cell Signal; 2024 May; 117():111112. PubMed ID: 38387687
[TBL] [Abstract][Full Text] [Related]
34. RBM38 is a direct transcriptional target of E2F1 that limits E2F1-induced proliferation.
Feldstein O; Ben-Hamo R; Bashari D; Efroni S; Ginsberg D
Mol Cancer Res; 2012 Sep; 10(9):1169-77. PubMed ID: 22798430
[TBL] [Abstract][Full Text] [Related]
35.
Zou F; Tu R; Duan B; Yang Z; Ping Z; Song X; Chen S; Price A; Li H; Scott A; Perera A; Li S; Xie T
Proc Natl Acad Sci U S A; 2020 Feb; 117(7):3603-3609. PubMed ID: 32015133
[TBL] [Abstract][Full Text] [Related]
36. 5-methylcytosine (m
Zhang Y; Zhang LS; Dai Q; Chen P; Lu M; Kairis EL; Murugaiah V; Xu J; Shukla RK; Liang X; Zou Z; Cormet-Boyaka E; Qiu J; Peeples ME; Sharma A; He C; Li J
Proc Natl Acad Sci U S A; 2022 Oct; 119(42):e2123338119. PubMed ID: 36240321
[TBL] [Abstract][Full Text] [Related]
37. Multi-omics analysis of expression and prognostic value of NSUN members in prostate cancer.
Sun G; Ma S; Zheng Z; Wang X; Chen S; Chang T; Liang Z; Jiang Y; Xu S; Liu R
Front Oncol; 2022; 12():965571. PubMed ID: 35978830
[TBL] [Abstract][Full Text] [Related]
38. Epigenetic addition of m
Ding S; Liu H; Liu L; Ma L; Chen Z; Zhu M; Liu L; Zhang X; Hao H; Zuo L; Yang J; Wu X; Zhou P; Huang F; Zhu F; Guan W
Cell Death Dis; 2024 Jan; 15(1):39. PubMed ID: 38216565
[TBL] [Abstract][Full Text] [Related]
39. mRNA m5C controls adipogenesis by promoting CDKN1A mRNA export and translation.
Liu Y; Zhao Y; Wu R; Chen Y; Chen W; Liu Y; Luo Y; Huang C; Zeng B; Liao X; Guo G; Wang Y; Wang X
RNA Biol; 2021 Nov; 18(sup2):711-721. PubMed ID: 34570675
[TBL] [Abstract][Full Text] [Related]
40. The long non-coding RNA FOXD2-AS1 promotes bladder cancer progression and recurrence through a positive feedback loop with Akt and E2F1.
Su F; He W; Chen C; Liu M; Liu H; Xue F; Bi J; Xu D; Zhao Y; Huang J; Lin T; Jiang C
Cell Death Dis; 2018 Feb; 9(2):233. PubMed ID: 29445134
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
